SEL-302

· Selecta Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEL-302, covering 2024-09-24 to 2024-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA [Phase 1, Phase 2]

See pricing